Stock RAFA RAFARMA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Rafarma Pharmaceuticals, Inc.

Equities

RAFA

US75062C1009

Delayed OTC Markets
Other stock markets
 10:56:18 2024-04-26 am EDT 		5-day change 1st Jan Change
0.1105 USD +8.33% Intraday chart for Rafarma Pharmaceuticals, Inc. +2.31% -57.71%
2021 RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park CI
2021 Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
AQ
Rafarma Pharmaceutical news update
AQ
Rafarma Pharmaceuticals : RAFA Financials Q2
PU
Rafarma Pharmaceuticals strengthens its position in Central Asia
AQ
Rafarma’s Slavich Noya Technology Division Expands Printing Production
AQ
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research
AQ
RAFA To Add Major Component to the Tashkent Pharma Park
AQ
RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park
CI
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5
AQ
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
GL
Letter to Shareholders from the Chairman of the Board Ilya Shpurov
GL
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build
GL
Rafarma’s Global Pharmaceutical Strategy At A Glance
GL
Rafarma To Expand Proton Therapy Centers
GL
Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers
CI
Rafarma and Haifa Technopark Enter Talks for Joint Venture
GL
Rafarma Embarks on Aggressive Global Partnerships Plan
GL
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan
GL
Rafarma Pharmaceuticals, Inc. Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan
CI
Vaccines Lab Sdn Bhd Enters Master Strategic Joint Venture Agreement with Rafarma Pharmaceuticals Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RAFA Stock
  4. News Rafarma Pharmaceuticals, Inc.